As the infants born to GDM Class A1 women at 36 weeks of
gestation or more do not have an increased incidence of morbidities, routine monitoring of such infants for blood glucose for an extended period adds unjustified laboratory and personnel
expense, is traumatic to the newborn infants, and prolongs their
length of stay in the SCN